Solaxa
Company

Solaxa

Biotechnology Research 7272 Wisconsin Ave 10 employees
Employees
10
Contacts
3
Emails
3
Phones
1

Solaxa Overview

Headquarters
7272 Wisconsin Ave
Website
www.solaxa.com
Industry
Biotechnology Research
Employees
10
Founded
2021
Funding
670.0K
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Solaxa

Belonging starts in the body. When nerve damage occurs, it disrupts sensation that affects physical function and severs bonds with what brings us joy and makes us who we are. We restore what it means to be human – feeling alive and connected to the world again. Solaxa is a clinical-stage biopharmaceutical company developing life-altering solutions that reignite function lost from neurodegenerative disease and nerve damage. We help adults and children get back the confidence in movement and the ability to participate in activities that bring a sense of belonging. As a public benefit corporation, we have a responsibility to deliver impactful solutions; we serve people for the greater good. We measure success by the human experience — by delivering solutions and care that help people regain independence and the ability to connect with the world around them. Because when you feel at home in your body, you belong everywhere.

Solaxa Contact Details

People in AeroLeads
3
With contact data
3
Email contacts
3
100.0% coverage
Phone contacts
1
33.3% coverage

Solaxa Org Chart

Sample employees and titles
Name Title Contact
Christian Walker CEO & Founder at Solaxa
Email
Amy Chappell, M.d., Faan Strategist in Neuroscience Drug
Email
Kerry Clem Biopharma Executive - C-suite & Board
Email Phone

Employees by Management Level

Individual contributor 2 profiles
Executive 1 profile

Compare Similar Companies to Solaxa